About Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ)
Rock Creek Pharmaceuticals, Inc., a pharmaceutical development company, focuses on the discovery, development, and commercialization of therapies for chronic inflammatory disease and neurologic disorders. Its lead compound is Anatabine citrate, a small molecule, cholinergic agonist, which exhibits anti-inflammatory pharmacological characteristics, with a mechanism of action distinct from other anti-inflammatory drugs available, such as biologics, steroids, and non-steroidal anti-inflammatories. The company was formerly known as Star Scientific, Inc. and changed its name to Rock Creek Pharmaceuticals, Inc. in June 2014. Rock Creek Pharmaceuticals, Inc. is headquartered in Sarasota, Florida. On September 27, 2016, Rock Creek Pharmaceuticals, Inc., along with its affiliates, filed a voluntary petition for liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware.
Industry, Sector and Symbol
Industry Medicinals & botanicals
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
EPS (Most Recent Fiscal Year)N/A
Return on EquityN/A
Return on AssetsN/A
Rock Creek Pharmaceuticals (OTCMKTS:RCPIQ) Frequently Asked Questions
What is Rock Creek Pharmaceuticals' stock symbol?
Rock Creek Pharmaceuticals trades on the OTCMKTS under the ticker symbol "RCPIQ."
How were Rock Creek Pharmaceuticals' earnings last quarter?
Rock Creek Pharmaceuticals Inc (OTCMKTS:RCPIQ) released its quarterly earnings data on Monday, November, 11th. The company reported ($0.02) EPS for the quarter. The firm earned $2.26 million during the quarter, compared to analysts' expectations of $1.70 million. View Rock Creek Pharmaceuticals' Earnings History.
Who are some of Rock Creek Pharmaceuticals' key competitors?
Some companies that are related to Rock Creek Pharmaceuticals include Actelion (ALIOF), Stada Arzneimittel (STDAF), USANA Health Sciences (USNA), Foamix Pharmaceuticals (FOMX), Chromadex (CDXC), Mediwound (MDWD), Pharmacyte Biotech (PMCB), Natural Alternatives International (NAII), Mannatech (MTEX), China Jo-Jo Drugstores (CJJD), GLG Life Tech (GLGLF), Cyanotech (CYAN), ImmuDyne (IMMD), FitLife Brands (FTLF) and Nutra Pharma (NPHC).
Who are Rock Creek Pharmaceuticals' key executives?
Rock Creek Pharmaceuticals' management team includes the folowing people:
- Dr. Michael John Mullan MBBS (M.D., ), Ph.D., Chairman, Chief Exec. Officer and Pres (Age 61)
- Dr. Ryan K. Lanier Ph.D., Chief Scientific Officer
- Mr. Theodore Jenkins, VP of Corp. Strategy, Devel. and Investor Relations
- Dr. Curtis Wright IV, M.D., MPH, Sr. VP and Medical & Clinical Director (Age 69)
- Mr. Richard Milam, Director of Quality Assurance and New Product Devel.
Has Rock Creek Pharmaceuticals been receiving favorable news coverage?
News articles about RCPIQ stock have trended somewhat positive this week, according to Accern. Accern identifies positive and negative news coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Rock Creek Pharmaceuticals earned a media sentiment score of 0.13 on Accern's scale. They also gave news headlines about the company an impact score of 45.69 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next few days.
How do I buy shares of Rock Creek Pharmaceuticals?
Shares of RCPIQ can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Rock Creek Pharmaceuticals' stock price today?
One share of RCPIQ stock can currently be purchased for approximately $0.0008.
How big of a company is Rock Creek Pharmaceuticals?
Rock Creek Pharmaceuticals has a market capitalization of $140,000.00.
How can I contact Rock Creek Pharmaceuticals?
Rock Creek Pharmaceuticals' mailing address is 2040 WHITFIELD AVE. SUITE 300, SARASOTA FL, 34243. The company can be reached via phone at 844-727-0727 or via email at [email protected]
MarketBeat Community Rating for Rock Creek Pharmaceuticals (RCPIQ)MarketBeat's community ratings are surveys of what our community members think about Rock Creek Pharmaceuticals and other stocks. Vote "Outperform" if you believe RCPIQ will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCPIQ will underperform the S&P 500 over the long term. You may vote once every thirty days.